• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Pharmacotherapy of Smoking Cessation: Current & Future Status

Pharmacotherapy of Smoking Cessation: Current & Future Status

9781617616013
359.04 zł
323.13 zł Save 35.91 zł Tax included
Lowest price within 30 days before promotion: 323.13 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Realising the impact of smoking on human beings, the US Public Health Service updated its 2000 Guidelines for Treating Tobacco Use and Dependence in 2008 and the WHO released the MPOWER package. Both guidelines aim to counter the tobacco epidemic and reduce its deadly toll. Smoking is a leading preventable cause of mortality in the U.S. and world-wide. Tobacco use is growing fastest in the low income countries due to steady population growth coupled with tobacco industry targeting, ensuing that millions of people get fatally addicted every year. The data made available through litigation has shown that the tobacco industry has invested a tremendous amount of time and money studying young adult smoking patterns. This book will illuminate these various aspects of smoking addiction.
Product Details
73588
9781617616013
9781617616013

Data sheet

Publication date
2011
Issue number
1
Cover
paperback
Pages count
69
Dimensions (mm)
215.00 x 140.00
Weight (g)
120
  • Preface; Neurobiology of nicotine dependence; Pharmacotherapy; Nicotine Replacement Therapy (NRT); Nicotine gum; Transdermal nicotine patch; Nicotine lozenge; Nicotine nasal spray; Nicotine inhaler; Status and newer recommendations for NRT; Bupropion; Varenicline; Clonidine; Nortriptyline; Nicotinic or Non-Nicotinic Therapies Under Investigation Nicotine vaccines; Rimonabant; Mecamylamine; Inhibitors of Nicotine metabolism; Opioid antagonists; Antidepressants; GABAergic agents; Drug Therapy in Pregnant Females; Critical issues of pharmacotherapy; Index.
Comments (0)